Kuala Lumpur, 11 February 2026 – Sunway Healthcare Holding, the healthcare arm of Malaysian conglomerate Sunway Group, is taking decisive steps toward what could become one of Malaysia’s most significant healthcare listings in recent years, appointing six major investment banks as underwriters for its upcoming initial public offering (IPO) on Bursa Malaysia.
The IPO marks a pivotal moment not only for Sunway Healthcare but also for Malaysia’s broader capital markets and healthcare ecosystem, reflecting strong investor appetite for healthcare infrastructure amid rising regional demand for quality medical services.
Sunway Healthcare confirmed that Maybank Investment Bank, AmInvestment Bank, Affin Hwang Investment Bank, CIMB Investment Bank, RHB Investment Bank, and Kenanga Investment Bank have been appointed to manage the offering, which is expected to launch its prospectus in the first quarter of 2026.
A Multi-Billion Ringgit Healthcare Offering
Market expectations surrounding the IPO remain elevated, with earlier reports suggesting the offering could raise more than RM3 billion and potentially value Sunway Healthcare at over RM15 billion. This would place the listing among the largest healthcare IPOs in Malaysia’s history and reinforce Bursa Malaysia’s attractiveness as a venue for large-scale listings.
The IPO is expected to involve approximately 1.97 billion shares, comprising 575 million new shares issued by the company and 1.39 billion existing shares offered by current investors to both institutional and retail participants.
Such a structure highlights dual objectives: enabling Sunway Healthcare to raise fresh capital for expansion while also allowing early stakeholders to partially realise their investments amid favourable market conditions.
Capital to Drive Hospital Expansion and Capacity Growth
Sunway Healthcare plans to utilise the IPO proceeds primarily to support the expansion of its hospital network, reflecting rising demand for private healthcare services in Malaysia and the wider ASEAN region.
Malaysia’s private healthcare sector has experienced sustained growth driven by multiple structural factors, including:
- Rising income levels and expanding middle-class population
- Increasing demand for specialised healthcare services
- Strong medical tourism inflows
- Growing ageing population across Southeast Asia
Sunway Healthcare’s strategy aligns closely with these long-term trends, positioning the group to scale its hospital infrastructure and clinical capabilities to capture growing regional demand.
Anchored by Malaysia’s Largest Private Hospital
Sunway Healthcare is already a major player in Malaysia’s private healthcare landscape. As of January 2026, the group operates 1,805 licensed beds across its hospital network and owns Sunway Medical Centre in Kuala Lumpur, which stands as the country’s largest private hospital.
Sunway Medical Centre has become a flagship healthcare institution not only for Malaysia but also for international patients seeking advanced medical treatment, reinforcing the group’s leadership position in the private healthcare segment.
Its existing operational scale provides a strong foundation for further expansion following the IPO, allowing the company to enhance service offerings, invest in medical technologies, and extend its geographic footprint.
Strategic Timing Amid Malaysia’s Capital Market Revival
The IPO comes at a time when Malaysia’s capital markets are regaining momentum, supported by strengthening macroeconomic fundamentals, improving investor confidence, and renewed foreign capital inflows.
Malaysia’s economic resilience, supported by stable inflation, improving fiscal consolidation, and strong investment inflows, has strengthened the ringgit and restored confidence among global investors. These factors have created favourable conditions for large-scale IPOs, particularly in sectors with long-term structural growth drivers such as healthcare.
Healthcare, in particular, has emerged as one of the most attractive investment themes globally, driven by demographic changes, rising healthcare expenditure, and advances in medical technologies.
Healthcare Sector Emerges as a Strategic Investment Frontier
The planned listing reflects a broader shift in Malaysia’s economic structure, where healthcare is increasingly recognised as a strategic sector capable of driving sustainable long-term growth.
Malaysia has positioned itself as a regional healthcare hub, supported by:
- Competitive treatment costs compared with developed markets
- High-quality medical infrastructure
- Skilled healthcare professionals
- Strong regulatory framework
These strengths have attracted international patients, particularly from Indonesia, Singapore, and the Middle East, reinforcing Malaysia’s role in the global medical tourism value chain.
Sunway Healthcare’s expansion strategy aligns with national priorities to strengthen healthcare capacity while contributing to Malaysia’s services-driven economic transformation.
Institutional Interest Signals Confidence in Malaysia’s Healthcare Future
The appointment of six major investment banks underscores strong institutional interest in the IPO, reflecting confidence in Sunway Healthcare’s business model and growth trajectory.
Institutional investors are increasingly allocating capital to healthcare assets, recognising the sector’s defensive characteristics and long-term demand resilience.
Healthcare infrastructure offers investors exposure to stable revenue streams driven by essential services, while also benefiting from structural growth trends tied to ageing populations and rising healthcare expenditure.
Sunway Healthcare’s IPO therefore represents more than a corporate milestone, it signals a broader maturation of Malaysia’s healthcare investment landscape.
Implications for Bursa Malaysia and Capital Market Development
The IPO is expected to further strengthen Bursa Malaysia’s pipeline of high-quality listings, particularly in sectors aligned with Malaysia’s economic transformation agenda.
Malaysia has seen increasing IPO activity across technology, healthcare, logistics, and industrial sectors, reflecting the country’s shift toward high-value industries.
Sunway Healthcare’s listing could serve as a catalyst for additional healthcare-related listings, accelerating capital formation and enhancing Malaysia’s competitiveness as a regional capital market hub.
Positioning Malaysia for Healthcare Leadership in ASEAN
Sunway Healthcare’s IPO represents a strategic milestone not only for the company but also for Malaysia’s broader ambition to become a regional healthcare leader.
With rising demand, expanding healthcare infrastructure, and growing investor interest, Malaysia’s healthcare sector is poised to play a central role in the country’s economic future.
As capital markets continue to deepen and investor confidence strengthens, Sunway Healthcare’s listing may mark the beginning of a new chapter, where healthcare emerges as one of Malaysia’s most important long-term investment frontiers.
